These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37124359)

  • 1. Prenatal Selective Serotonin Reuptake Inhibitor Exposure, Depression, and Brain Morphology in Middle Childhood: Results From the ABCD Study.
    Moreau AL; Voss M; Hansen I; Paul SE; Barch DM; Rogers CE; Bogdan R
    Biol Psychiatry Glob Open Sci; 2023 Apr; 3(2):243-254. PubMed ID: 37124359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
    Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
    JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine Exposure to Antidepressants or Maternal Depressive Symptoms and Offspring Brain White Matter Trajectories From Late Childhood to Adolescence.
    Koc D; El Marroun H; Stricker BH; Muetzel RL; Tiemeier H
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Feb; 9(2):217-226. PubMed ID: 37926188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
    Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in Neurodevelopmental Outcomes in Children with Prenatal SSRI Antidepressant Exposure.
    Rotem-Kohavi N; Oberlander TF
    Birth Defects Res; 2017 Jul; 109(12):909-923. PubMed ID: 28714603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age.
    Oberlander TF; Papsdorf M; Brain UM; Misri S; Ross C; Grunau RE
    Arch Pediatr Adolesc Med; 2010 May; 164(5):444-51. PubMed ID: 20439795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Prenatal Selective Serotonin Reuptake Inhibitor Antidepressant Exposure and Maternal Mood on Physical Activity, Dietary Intake, and Markers of Adiposity at Age 6 Years.
    Hutchison SM; Mâsse LC; Glier MB; Brain U; Devlin AM; Oberlander TF
    J Dev Behav Pediatr; 2019 May; 40(4):266-274. PubMed ID: 30950906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal exposure to selective serotonin reuptake inhibitors and non-verbal cognitive functioning in childhood.
    El Marroun H; White TJ; Fernandez G; Jaddoe VW; Verhulst FC; Stricker BH; Tiemeier H
    J Psychopharmacol; 2017 Mar; 31(3):346-355. PubMed ID: 27624153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between maternal depressive symptoms and selective serotonin reuptake inhibitor antidepressant treatment on internalising and anxiety behaviours in children: 12-year longitudinal study.
    Hutchison SM; Brain U; Grunau RE; Kuzeljevic B; Irvine M; Mâsse LC; Oberlander TF
    BJPsych Open; 2023 Feb; 9(2):e26. PubMed ID: 36721917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-uterine exposure to selective serotonin reuptake inhibitors (SSRIs), maternal psychopathology, and neurodevelopment at age 2.5years - Results from the prospective cohort SMOK study.
    van der Veere CN; de Vries NKS; van Braeckel KNJA; Bos AF
    Early Hum Dev; 2020 Aug; 147():105075. PubMed ID: 32504880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.
    Oberlander TF; Grunau RE; Fitzgerald C; Papsdorf M; Rurak D; Riggs W
    Pediatrics; 2005 Feb; 115(2):411-25. PubMed ID: 15687451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children.
    El Marroun H; White TJ; van der Knaap NJ; Homberg JR; Fernández G; Schoemaker NK; Jaddoe VW; Hofman A; Verhulst FC; Hudziak JJ; Stricker BH; Tiemeier H
    Br J Psychiatry; 2014 Aug; 205(2):95-102. PubMed ID: 25252317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.
    Gur TL; Kim DR; Epperson CN
    Psychopharmacology (Berl); 2013 Jun; 227(4):567-82. PubMed ID: 23681158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
    Salisbury AL; O'Grady KE; Battle CL; Wisner KL; Anderson GM; Stroud LR; Miller-Loncar CL; Young ME; Lester BM
    Am J Psychiatry; 2016 Feb; 173(2):147-57. PubMed ID: 26514656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.
    Eke AC; Saccone G; Berghella V
    BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.
    Grzeskowiak LE; Gilbert AL; Sørensen TI; Olsen J; Sørensen HT; Pedersen LH; Morrison JL
    Ann Epidemiol; 2013 Nov; 23(11):681-7. PubMed ID: 24113367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hub distribution of the brain functional networks of newborns prenatally exposed to maternal depression and SSRI antidepressants.
    Rotem-Kohavi N; Williams LJ; Muller AM; Abdi H; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Depress Anxiety; 2019 Aug; 36(8):753-765. PubMed ID: 31066992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study.
    Lupattelli A; Mahic M; Handal M; Ystrom E; Reichborn-Kjennerud T; Nordeng H
    BJOG; 2021 Nov; 128(12):1917-1927. PubMed ID: 33982858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatrician and family physician prescription of selective serotonin reuptake inhibitors.
    Rushton JL; Clark SJ; Freed GL
    Pediatrics; 2000 Jun; 105(6):E82. PubMed ID: 10835095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 6-year longitudinal study: Are maternal depressive symptoms and Selective Serotonin Reuptake Inhibitor (SSRI) antidepressant treatment during pregnancy associated with everyday measures of executive function in young children?
    Hutchison SM; Mâsse LC; Brain U; Oberlander TF
    Early Hum Dev; 2019 Jan; 128():21-26. PubMed ID: 30447406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.